Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Update: $AGN CEO Chris Moreau - Chronic Cough Drug Program

View:

Post by bmreed on Jan 30, 2023 12:20pm

Update: $AGN CEO Chris Moreau - Chronic Cough Drug Program

News Update: Algernon Pharmaceuticals $AGN w CEO Christopher Moreau - Pitch, Deep Dive and Q&A - https://youtu.be/zpvV0-fELgc

CEO Christopher Moreau provides an update on its Ifendprodil drug program targeting chronic, or refractory, cough. The company is planning a phase 2b study for later this year.